What drives this editor nuts faster than almost anything else? Conspiracy theories about pharma and biotech, particularly the ones that insist
that companies are sitting on the cure for cancer so that they can get ever richer on non-curative therapies for the disease.
It isn't that mobile health devices and other,
similar technologies aren't a potential boon for things like clinical trial data handling. It's just that we aren't quite at the point where we can
realize their true worth or even use them properly in most cases.
The field of cancer genomics is rapidly advancing both in
knowledge and in relevance to the treatment of cancer, as detailed genetic profiling of human cancers has now become possible. Mass spec imaging is helping
to take that farther.